VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 452 filers reported holding VANECK VECTORS ETF TR in Q1 2019. The put-call ratio across all filers is 0.95 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $925,704 | -10.6% | 34,400 | 0.0% | 0.21% | -0.5% |
| Q2 2023 | $1,035,784 | -6.9% | 34,400 | 0.0% | 0.21% | -5.4% |
| Q1 2023 | $1,112,840 | +12.9% | 34,400 | 0.0% | 0.22% | +7.3% |
| Q4 2022 | $985,904 | +10.2% | 34,400 | -7.3% | 0.21% | -4.2% |
| Q3 2022 | $895,000 | -17.7% | 37,100 | -6.7% | 0.22% | -11.9% |
| Q2 2022 | $1,088,000 | -28.6% | 39,750 | 0.0% | 0.24% | -17.6% |
| Q1 2022 | $1,524,000 | +19.7% | 39,750 | 0.0% | 0.30% | +16.1% |
| Q4 2021 | $1,273,000 | +8.7% | 39,750 | 0.0% | 0.26% | -6.6% |
| Q3 2021 | $1,171,000 | -11.0% | 39,750 | +2.7% | 0.27% | -10.2% |
| Q2 2021 | $1,315,000 | +4.5% | 38,700 | 0.0% | 0.30% | -15.6% |
| Q1 2021 | $1,258,000 | -9.8% | 38,700 | 0.0% | 0.36% | -15.7% |
| Q4 2020 | $1,394,000 | -28.1% | 38,700 | -21.8% | 0.43% | -39.5% |
| Q3 2020 | $1,938,000 | +8.9% | 49,500 | +2.1% | 0.71% | -1.1% |
| Q2 2020 | $1,779,000 | +59.3% | 48,500 | 0.0% | 0.71% | +38.4% |
| Q1 2020 | $1,117,000 | -22.2% | 48,500 | -1.1% | 0.52% | +11.7% |
| Q4 2019 | $1,436,000 | +10.9% | 49,056 | +1.1% | 0.46% | -9.4% |
| Q3 2019 | $1,295,000 | +4.4% | 48,500 | 0.0% | 0.51% | -2.3% |
| Q2 2019 | $1,240,000 | +14.1% | 48,500 | 0.0% | 0.52% | +2.4% |
| Q1 2019 | $1,087,000 | +6.3% | 48,500 | 0.0% | 0.51% | +11.6% |
| Q4 2018 | $1,023,000 | +30.7% | 48,500 | +14.7% | 0.46% | +13.1% |
| Q3 2018 | $783,000 | -17.1% | 42,300 | 0.0% | 0.40% | -16.4% |
| Q2 2018 | $944,000 | +1.5% | 42,300 | 0.0% | 0.48% | +4.5% |
| Q1 2018 | $930,000 | -5.4% | 42,300 | 0.0% | 0.46% | -7.2% |
| Q4 2017 | $983,000 | +1.2% | 42,300 | 0.0% | 0.50% | -1.0% |
| Q3 2017 | $971,000 | +4.0% | 42,300 | 0.0% | 0.50% | -1.8% |
| Q2 2017 | $934,000 | -3.2% | 42,300 | 0.0% | 0.51% | -11.9% |
| Q1 2017 | $965,000 | +9.0% | 42,300 | -0.0% | 0.58% | +0.9% |
| Q4 2016 | $885,000 | -20.8% | 42,303 | 0.0% | 0.58% | -25.6% |
| Q3 2016 | $1,118,000 | -4.6% | 42,303 | 0.0% | 0.77% | -16.4% |
| Q2 2016 | $1,172,000 | – | 42,303 | – | 0.93% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| New Harbor Financial Group, LLC | 2,418,400 | $77,461,000 | 26.62% |
| Brevan Howard Capital Management LP | 1,000,000 | $32,030,000 | 23.21% |
| Windmill Hill Asset Management Ltd | 844,600 | $27,053,000 | 19.48% |
| Memorial Sloan Kettering Cancer Center | 738,500 | $23,654,000 | 14.86% |
| New Harbor Financial Group, LLC | 1,286,391 | $41,203,000 | 14.16% |
| Eschler Asset Management LLP | 300,000 | $9,609,000 | 12.30% |
| Hollow Brook Wealth Management LLC | 712,669 | $22,827,000 | 11.71% |
| Grand Central Investment Group | 284,547 | $9,114,000 | 10.90% |
| Baymount Management LP | 500,000 | $16,015,000 | 9.54% |
| Nokomis Capital, L.L.C. | 512,628 | $16,419,000 | 6.93% |